| Impaired glymphatic perfusion after strokes revealed by contrast-enhanced MRI: a new target for fibrinolysis? T Gaberel, C Gakuba, R Goulay, SM De Lizarrondo, JL Hanouz, E Emery, ... Stroke 45 (10), 3092-3096, 2014 | 489 | 2014 |
| Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial U Fischer, J Kaesmacher, D Strbian, O Eker, C Cognard, PS Plattner, ... The Lancet 400 (10346), 104-115, 2022 | 304 | 2022 |
| Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi S Martinez de Lizarrondo, C Gakuba, BA Herbig, Y Repessé, C Ali, ... Circulation 136 (7), 646-660, 2017 | 185 | 2017 |
| General anesthesia inhibits the activity of the “glymphatic system” C Gakuba, T Gaberel, S Goursaud, J Bourges, C Di Palma, A Quenault, ... Theranostics 8 (3), 710, 2018 | 184 | 2018 |
| Subarachnoid hemorrhage severely impairs brain parenchymal cerebrospinal fluid circulation in nonhuman primate R Goulay, J Flament, M Gauberti, M Naveau, N Pasquet, C Gakuba, ... Stroke 48 (8), 2301-2305, 2017 | 176 | 2017 |
| Hyperfibrinolysis increases blood–brain barrier permeability by a plasmin-and bradykinin-dependent mechanism OA Marcos-Contreras, S Martinez de Lizarrondo, I Bardou, C Orset, ... Blood, The Journal of the American Society of Hematology 128 (20), 2423-2434, 2016 | 169 | 2016 |
| The role of plasminogen activators in stroke treatment: fibrinolysis and beyond AM Thiebaut, M Gauberti, C Ali, SM De Lizarrondo, D Vivien, M Yepes, ... The Lancet Neurology 17 (12), 1121-1132, 2018 | 167 | 2018 |
| Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence D Vivien, M Gauberti, A Montagne, G Defer, E Touzé Journal of Cerebral Blood Flow & Metabolism 31 (11), 2119-2134, 2011 | 140 | 2011 |
| Ultra-sensitive molecular MRI of vascular cell adhesion molecule-1 reveals a dynamic inflammatory penumbra after strokes M Gauberti, A Montagne, OA Marcos-Contreras, A Le Béhot, E Maubert, ... Stroke 44 (7), 1988-1996, 2013 | 138 | 2013 |
| Crucial role of the protein corona for the specific targeting of nanoparticles M Mahmoudi, S Sheibani, AS Milani, F Rezaee, M Gauberti, R Dinarvand, ... Nanomedicine 10 (2), 215-226, 2015 | 122 | 2015 |
| Ischemia-reperfusion injury after endovascular thrombectomy for ischemic stroke M Gauberti, B Lapergue, S Martinez de Lizarrondo, D Vivien, S Richard, ... Stroke 49 (12), 3071-3074, 2018 | 120 | 2018 |
| Tissue plasminogen activator prevents white matter damage following stroke F Correa, M Gauberti, J Parcq, R Macrez, Y Hommet, P Obiang, ... Journal of Experimental Medicine 208 (6), 1229-1242, 2011 | 104 | 2011 |
| Brain-released alarmins and stress response synergize in accelerating atherosclerosis progression after stroke S Roth, V Singh, S Tiedt, L Schindler, G Huber, A Geerlof, DJ Antoine, ... Science translational medicine 10 (432), eaao1313, 2018 | 103 | 2018 |
| Molecular magnetic resonance imaging of brain–immune interactions M Gauberti, A Montagne, A Quenault, D Vivien Frontiers in cellular neuroscience 8, 389, 2014 | 90 | 2014 |
| GpIbα-VWF blockade restores vessel patency by dissolving platelet aggregates formed under very high shear rate in mice A Le Behot, M Gauberti, S Martinez De Lizarrondo, A Montagne, ... Blood, The Journal of the American Society of Hematology 123 (21), 3354-3363, 2014 | 87 | 2014 |
| Potential of olfactory ensheathing cells from different sources for spinal cord repair A Mayeur, C Duclos, A Honore, M Gauberti, L Drouot, JC do Rego, ... PloS one 8 (4), e62860, 2013 | 86 | 2013 |
| Ultra-sensitive molecular MRI of cerebrovascular cell activation enables early detection of chronic central nervous system disorders A Montagne, M Gauberti, R Macrez, A Jullienne, A Briens, JS Raynaud, ... Neuroimage 63 (2), 760-770, 2012 | 86 | 2012 |
| Molecular magnetic resonance imaging of endothelial activation in the central nervous system M Gauberti, AP Fournier, F Docagne, D Vivien, SM de Lizarrondo Theranostics 8 (5), 1195, 2018 | 84 | 2018 |
| Antibodies Preventing the Interaction of Tissue-Type Plasminogen Activator With N-Methyl-d-Aspartate Receptors Reduce Stroke Damages and Extend the … R Macrez, P Obiang, M Gauberti, B Roussel, A Baron, J Parcq, F Cassé, ... Stroke 42 (8), 2315-2322, 2011 | 83 | 2011 |
| Absence of TI-VAMP/Vamp7 leads to increased anxiety in mice L Danglot, K Zylbersztejn, M Petkovic, M Gauberti, H Meziane, R Combe, ... Journal of Neuroscience 32 (6), 1962-1968, 2012 | 80 | 2012 |
Martinez De Lizarrondo, SaraINSERM U1237 - PhINDVerified email at cyceron.fr
